Trial Profile
A retrospective study to evaluate safety and efficacy of Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension; Respiratory distress syndrome
- Focus Therapeutic Use
- 09 Oct 2015 New trial record